Effect of the gastrin-releasing peptide antagonist BIM 26226 and lanreotide on an acinar pancreatic carcinoma

European Journal of Pharmacology

Volumn 347, Issue 1, 1998, Pages 77-86

  Damgé, Christiane ^a   Hajri, Amor ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

Acinar pancreatic cancer; Bombesin GRP receptor antagonist; Exocrine pancreas; Gastrin releasing peptide; Receptor; Somatostatin analogue

Indexed keywords

ANGIOPEPTIN; BOMBESIN[6-13][6 DEXTRO PENTAFLUOROPHENYLALANINE 11 DEXTRO ALANINE] METHYL ESTER; GASTRIN RELEASING PEPTIDE;

ACINAR CELL; ANIMAL CELL; ARTICLE; DRUG EFFECT; GASTRIN RELEASE; GROWTH REGULATION; NONHUMAN; PANCREAS CARCINOMA; PANCREAS SECRETION; PRIORITY JOURNAL; RAT; TUMOR GROWTH; TUMOR VOLUME;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BOMBESIN; CELL DIVISION; CELL MEMBRANE; GASTRIN-RELEASING PEPTIDE; IODINE RADIOISOTOPES; MALE; NEOPLASM TRANSPLANTATION; PANCREATIC NEOPLASMS; PEPTIDE FRAGMENTS; PEPTIDES, CYCLIC; RATS; RATS, INBRED LEW; SOMATOSTATIN; THYMIDINE; TRITIUM; TUMOR CELLS, CULTURED;

EID: 0032540211     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00088-0     Document Type: Article

References (58)

1. Alexander R.W., Upp J.R. Jr., Poston G.J., Townsend C.M. Jr., Singh P., Thompson J.C. Bombesin inhibits growth of human pancreatic adenocarcinoma in nude mice. Pancreas. 3:1988;297-302.
2. Barrie R., Woltering E.A., Hajarizadeh H., Mueller C., Ure T., Fletcher W.S. Inhibition of angiogenesis by somatostatin and somatostatin-like compounds is structurally dependent. J. Surg. Res. 55:1993;446-450.
3. Bogden A.E., Taylor J.E., Moreau J.P., Coy D.H. Treatment of R-3327 prostate tumors with a somatostatin analogue (Somatuline) as adjuvant therapy following surgical castration. Cancer Res. 50:1990;2646-2650.
4. Bogden A.E., Taylor J.E., Moreau J.P., Coy D.H., Le Page D.J. Response of human lung tumor xenografts to treatment with somatostatin analogue (Somatuline). Cancer Res. 50:1990;4360-4365.
5. Bold R.J., Lowry P.S., Ishizuka J., Battey J.F., Townsend C.M. Jr., Thompson J.C. Bombesin stimulates the in vitro growth of a human gastric cancer cell line. J. Cell Physiol. 161:1994;519-525.
6. Borysewicz R., Ren K.J., Mokotoff M., Lee P.C. Direct effect of bombesin on pancreatic and gastric growth in suckling rats. Regul. Pept. 41:1992;157-169.
7. Bruns C., Raulf F., Hoyer D., Schloos J., Lubbert H., Weckbecker G. Binding properties of somatostatin receptor subtypes. Metab. Clin. Exp. 45:1996;17-20. (Suppl. 1).
8. Chu K.U., Ishizuka J., Battey J.F., Uchida T., Beauchamp R.D., Townsend C.M. Jr., Thompson J.C. Mechanisms of bombesin on growth of gastrinoma (PT) in vivo. Dig. Dis. Sci. 41:1996;2180-2186.
9. Coy D.H., Taylor J.E. Receptor-specific somatostatin analogs. Correlations with biological activity. Metabolism. 45:1996;21-23. Suppl. 1.
10. Coy D.H., Mungan Z., Rossowski W.J., Cheng B.L., Lin J.T., Mrozinski J.E. Jr., Jensen R.T. Development of a potent bombesin receptor antagonist with prolonged in vivo inhibitory activity on bombesin-stimulated amylase and protein release in the rat. Peptides. 13:1992;775-781.
11. Cuttita F., Carney D.N., Mulshine J., Moody T.W., Fedorko J., Fisher A., Minna J.D. Bombesin like peptides can function as autocrine growth factors in human small cell lung cancer. Nature. 316:1985;823-826.
12. Damgé C., Hajri A., Lhoste E., Aprahamian M. Comparative effect of chronic bombesin, gastrin-releasing peptide and caerulein on the rat pancreas. Regul. Pept. 20:1988;141-150.
13. Danielsson A. Technique for measuring amylase secretion from pieces of mouse pancreas. Anal. Biochem. 59:1974;220-234.
14. Delesque N., Buscail L., Estève J.P., Rauly I., Zeggari M., Saint-Laurent N., Bell G.I., Schally A.V., Vaysse N., Susini C. A tyrosine phosphatase is associated with the somatostatin receptor. Ciba Found. Symp. 190:1995;187-196.
15. Dietrich J.B., Hildebrand P., Jeker L.B., Pansky A., Eberle A.N., Beglinger C. Effects of BIM 26226, a potent and specific bombesin receptor antagonist, on amylase release and binding of bombesin-like peptides to AR4-2J cells. Regul. Pept. 53:1994;165-173.
16. Douglas B.R., Woutersen R.A., Jansen J.B.M.J., De Jong A.J.L., Rovati L.C., Lamers C.B.H.W. Influence of cholecystokinin antagonist on the effects of cholecystokinin and bombesin on azaserine-induced lesions in rat pancreas. Gastroenterology. 96:1989;462-469.
17. Frystyk J., Skjaerbaek C., Alexander N., Emanuelsson H., Suryapranata H., Beyer H., Foegh M., Orskov H. Lanreotide reduces serum free and total insulin-like growth factor-I after angioplasty. Circulation. 94:1996;2465-2471.
18. Hajri A., Aprahamian M., Damgé C. Effect of prolonged administration of long-acting somatostatin on caerulein, CCK-8 and GRP induced pancreatic growth in the rat. Regul. Pept. 32:1991;227-237.
19. Hajri A., Bruns C., Marbach P., Aprahamian M., Longnecker D.S., Damgé C. Inhibition of the growth of transplanted rat pancreatic acinar carcinoma with octreotide. Eur. J. Cancer. 27:1991;1247-1252.
20. Hajri A., Balboni G., Koenig M., Garaud J.C., Damgé C. Gastrin-releasing peptide: in vivo and in vitro growth effects on an acinar pancreatic carcinoma. Cancer Res. 52:1992;3726-3732.
21. Hajri A., Koenig M., Balboni G., Damgé C. Expression and characterization of gastrin-releasing peptide receptor in normal and cancerous pancreas. Pancreas. 12:1996;25-35.
22. Hierowski M.T., Liebow C., du Sapin K., Schally A.V. Stimulation by somatostatin of dephosphorylation of membrane proteins in pancreatic cancer MIA PaCa-2 cell line. FEBS Lett. 179:1985;252-256.
23. Jensen R.T., Coy D.H. Progress in the development of potent bombesin receptor antagonists. Trends Pharmacol. Sci. 12:1991;13-19.
24. Lehy T., Puccio F., Chariot J., Labeille D. Stimulating effect of bombesin on the growth of gastrointestinal tract and pancreas in suckling rats. Gastroenterology. 90:1986;1942-1946.
25. Lhoste E.F., Longnecker D.S. Effects of bombesin and caerulein on early stages of carcinogenesis induced by azaserine in the rat pancreas. Cancer Res. 47:1987;3272-3277.
26. Lhoste E., Aprahamian M., Pousse A., Hoeltzel A., Stock-Damgé C. Trophic effect of bombesin on the rat pancreas: is it mediated by the release of gastrin or cholecystokinin? Peptides. 6:1985;89-97. Suppl. 3.
27. Lhoste E.F., Aprahamian M., Balboni G., Stock-Damgé C. Evidence for a direct trophic effect of bombesin on the mouse pancreas: in vivo and cell culture studies. Regul. Pept. 24:1989;45-54.
28. Liebow C., Reilly C., Serrano M., Schally A.V. Somatostain analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase. Proc. Natl. Acad. Sci. USA. 86:1989;2003-2007.
29. Liebow C., Lee M.T., Krebs L., Schally A.V. Bombesin may stimulate growth through up-regulation of EGF receptors. Pancreas. 7:1992;746.
30. Liebow C., Crean D.H., Lee M.T., Kamer A.R., Mang T.S., Schally A.V. Synergistic effects of bombesin and epidermal growth factor on cancers. Proc. Natl. Acad. Sci. USA. 91:1994;3804-3808.
31. Longnecker D.S., Roebuck B.D., Yager J.D., Lilja H.S., Siegmund B. Pancreatic carcinoma in azaserine-treated rats: induction, classification and dietary modulation of incidence. Cancer. 47:1981;1562-1572.
32. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
33. Mascardo R.N., Sherline P. Somatostatin inhibits rapid centrosomal separation and cell proliferation induced by epidermal growth factor. Endocrinology. 111:1982;1394-1396.
34. Meijers M., Garderen-Hoetmer A., Lamers C.B., Rovati L.C., Jansen J.B., Woutersen R.A. Effects of bombesin on the development of N-nitrosobis (2-oxopropyl) amine-induced pancreatic lesions in hamsters. Cancer Lett. 59:1991;45-50.
35. Meijers M., Appel M.J., van Garderen-Hoetmer A., Lamers C.B., Rovati L.C., Jansen J.B., Woutersen R.A. Effects of cholecystokinin and bombesin on development of azaserine-induced pancreatic tumours in rats: modulation by the cholecystokinin receptor antagonist lorglumide. Carcinogenesis. 13:1992;1525-1528.
36. Meijers M., Woutersen R.A., van Garderen-Hoetmer A., Bakker G.H., de Jong F.H., Foekens J.A., Klijn J.G. Effects of Sandostatin and castration on pancreatic carcinogenesis in rats and hamsters. Int. J. Cancer. 50:1992;246-251.
37. Miyata M., Rayford P.L., Thompson J.C. Hormonal (gastrin, secretin, cholecystokinin) and secretory effects of bombesin and duodenal acidification in dogs. Surgery. 87:1980;209-215.
38. Moreau S.C., Murphy W.A., Coy D.H. Comparison of Somatuline (BIM-23014) and somatostatin on endocrine and exocrine activities in the rat. Drug Dev. Res. 22:1991;79-93.
39. Morisset J. Somatostatin: a potential antigrowth factor for the exocrine pancreas. Regul. Pept. 10:1984;11-22.
40. Nagel W., Willig F., Peschke W., Schmidt F.H. Über die bestimmung von trypsin und chymotrypsin mit aminosaüre-p-nitroaniliden. Hoppe-Seyler's Z. Physiol. Chem. 340:1965;1-10.
41. Parmar H., Bogden A., Mollard M., De Rougé B., Phillips R.H., Lightman S.L. Somatostatin and somatostatin analogues in oncology. Cancer Treat. Rev. 16:1989;95-115.
42. Prévost G., Foehrlé E., Thomas F., Pihan I., Veber N., Starzec A., Israel L. Growth of human breast cancer cell lines is inhibited by the somatostatin analog BIM 23014. Endocrinology. 128:1991;323-329.
43. Prévost G., Bourgeois Y., Mormont C., Lerrant Y., Veber N., Poupon M.F., Thomas F. Characterization of somatostatin receptors and growth inhibition by the somatostatin analogue BIM 23014 in small cell lung carcinoma xenograft: SCLC-6. Life Sci. 55:1994;155-162.
44. Qin Y., Ertl T., Cai R.Z., Halmos G., Schally A.V. Inhibitory effect of bombesin receptor antagonist RC-3095 on the growth of human pancreatic cancer cells in vivo and in vitro. Cancer Res. 54:1994;1035-1041.
45. Qin Y., Ertl T., Cai R.Z., Horvath J.E., Groot K., Schally A.V. Antagonists of bombesin/gastrin-releasing peptide inhibit growth of SW-1990 human pancreatic adenocarcinoma and production of cyclic AMP. Int. J. Cancer. 63:1995;257-262.
46. Qin Y., Ertl T., Groot K., Horvath J., Cai R.Z., Schally A.V. Somatostatin analog RC-160 inhibits growth of CFPAC-1 human pancreatic cancer cells in vitro and intracellular production of cyclic adenosine monophosphate. Int. J. Cancer. 60:1995;694-700.
47. Reubi J.C., Laissue J.A. Multiple actions of somatostatin in neoplastic disease. Trends Pharmacol. Sci. 16:1995;110-115.
48. Richards G.M. Modifications of the diphenylamine reaction giving increased sensitivity and simplicity in the estimation of DNA. Anal. Biochem. 57:1974;369-376.
49. Sassolas G., Khalfallah Y., Chayvialle J.A., Cohen R., Merabet S., Casez J.P., Calvet P., Cabrera P. Effects of the somatostatin analog BIM 23014 on the secretion of growth hormone, thyrotropin, and digestive peptides in normal men. J. Clin. Endocrinol. Metab. 68:1989;239-246.
50. Schally A.V., Szepeshazi K., Qin Y., Halmos G., Ertl T., Groot K., Cai R.Z., Liebow C., Poston G.J. Antitumor effects of analogs of somatostatin and antagonists of bombesin/GRP in experimental models of pancreatic cancer. Int. J. Pancreatol. 16:1994;246-249.
51. Schneider, W.C., 1957. Determination of nucleic acids in tissues by pentose analysis. In: Colowick, S.P., Kaplan, N.O. (Eds.), Methods of Enzymology. Academic Press, New York, pp. 680-684.
52. Szepeshazi K., Schally A.V., Cai R.Z., Radulovic S., Milovanovic S., Szoke B. Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and high dose of somatostatin analogue RC-160 on nitrosamine-induced pancreatic cancers in hamsters. Cancer Res. 51:1991;5980-5986.
53. Szepeshazi K., Schally A.V., Groot K., Halmos G. Effect of bombesin, gastrin-releasing peptide (GRP) (14-27) and bombesin/GRP receptor antagonist RC-3095 on growth of nitrosamine-induced pancreatic cancers in hamsters. Int. J. Cancer. 54:1993;282-289.
54. Szepeshazi K., Halmos G., Groot K., Schally A.V. Combination treatment of nitrosamine-induced pancreatic cancers in hamsters with analogs of LH-RH and a bombesin/GRP antagonist. Int. J. Pancreatol. 16:1994;141-149.
55. Upp J.R. Jr., Olson D., Poston G.J., Alexander R.W., Townsend C.M. Jr., Thompson J.C. Inhibition of growth of two human pancreatic adenocarcinomas in vivo by somatostatin analog SMS 201-995. Am. J. Surg. 155:1988;29-35.
56. Viguerie N., Tahiri-Jouti N., Ayral A.M., Cambillau C., Scemama J.L., Bastié M.J., Knuhtsen S., Estève J.P., Pradayrol L., Susini C., Vaysse N. Direct inhibitory effects of somatostatin analog, SMS 201-995, in AR4-2J cell proliferation via pertussis toxin-sensitive guanosine triphosphate binding protein-independent mechanism. Endocrinology. 124:1989;1017-1025.
57. Wang Q.J., Knezetic J.A., Schally A.V., Pour P.M., Adrian T.E. Bombesin may stimulate proliferation of human pancreatic cancer cells through an autocrine pathway. Int. J. Cancer. 68:1996;528-534.
58. Woltering E.A., Watson J.C., Alperin-Lea R.C., Sharma C., Keenan E., Kurozawa D., Barrie R. Somatostatin analogs: angiogenesis inhibitors with novel mechanisms of action. Int. New Drugs. 15:1997;77-86.